Von Willebrand disease (VWD) is the most common inherited bleeding disorder, affecting up to 1% of the population [1]. Over the past two decades, there has been significant progress in understanding its pathophysiology, classification and clinical management. However, research in VWD continues to lag behind that of haemophilia—a rarer condition that has benefited from earlier and more sustained investment.